Taxane & cyclophosphamide vs anthracycline & taxane-based chemotherapy as adjuvant treatment for breast cancer: a pooled analysis of randomized controlled trials by the Hellenic Academy of Oncology

BACKGROUND: Adjuvant chemotherapy has an indisputable value for early breast cancer patients. Anthracycline and taxane-based regimens (TaxAC) have not been proven superior to taxane & cyclophosphamide (TC), a less toxic combination. Our objective was to estimate the cumulative evidence for non-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ntellas, Panagiotis, Spathas, Nikolaos, Agelaki, Sofia, Zintzaras, Elias, Saloustros, Emmanouil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383821/
https://www.ncbi.nlm.nih.gov/pubmed/30838092
http://dx.doi.org/10.18632/oncotarget.26632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383821/
https://www.ncbi.nlm.nih.gov/pubmed/30838092
http://dx.doi.org/10.18632/oncotarget.26632

Ejemplares similares